Showing results (171-180 of 259) with videos related to

Sort By:
Pageof 26
Plos One|February 23, 2012
iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancerIshtiaq Rehman, Caroline A Evans, Adam Glen, et al.
Frontiers in Oncology|February 22, 2021
Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor HeterogeneityFederico La Manna, Marta De Menna, Nikhil Patel, et al.
Frontiers in Oncology|July 14, 2020
Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor HeterogeneityFederico La Manna, Marta De Menna, Nikhil Patel, et al.
Urologic Oncology|October 10, 2017
Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomesBishoy M Faltas, Renee L Gennarelli, Elena Elkin, et al.
American Journal of Obstetrics and Gynecology|January 27, 2005
A single nucleotide A>G polymorphism at position -670 in the Fas gene promoter: relationship to preterm premature rupture of fetal membranes in multifetal pregnanciesRobin B Kalish, Daniel P Nguyen, Santosh Vardhana, et al.
European Urology|June 15, 2010
Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution?Gianluca Giannarini, Thomas M Kessler, Harriet C Thoeny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2013
Characterization and clinical relevance of ALDHbright populations in prostate cancerClémentine Le Magnen, Lukas Bubendorf, Cyrill A Rentsch, et al.
Plos One|December 9, 2014
The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell nichesBerna C Özdemir, Janine Hensel, Chiara Secondini, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 16, 2025
Multi-layer stratified oncology platform utilizing transcriptomics, prostate cancer organoids, and modeling of drug responseJuening Kang, Panagiotis Chouvardas, Andrew Maalouf, et al.
Urologic Oncology|September 14, 2014
Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practiceBas W G van Rhijn, James W Catto, Peter J Goebell, et al.
Pageof 26